Observational studyMultiple sclerosis and related disorders2025

Real-world infection risk in multiple sclerosis patients on long-term immunomodulatory treatments.

Clare McGarvey Lambert et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.